Invibio
Private Company
Funding information not available
Overview
Invibio is a leading global provider of implantable PEEK polymers, serving the medical device industry with a focus on spinal, orthopedic, and trauma applications. With over 20 years of clinical history, zero material-related recalls, and an estimated 15 million implanted devices, the company leverages its parent company Victrex's manufacturing to offer a trusted biomaterial platform. Its business model centers on supplying materials and offering innovation partnerships, helping device makers accelerate development, ensure regulatory compliance, and improve patient outcomes through enhanced implant design and imaging compatibility.
Technology Platform
Proprietary implantable-grade PEEK (polyetheretherketone) polymer and composite materials platform, including PEEK-OPTIMA™ and HA-enhanced grades, offering bone-like modulus, radiolucency, and biocompatibility for medical devices.
Opportunities
Risk Factors
Competitive Landscape
Invibio competes primarily against traditional metal implant materials (titanium, cobalt-chrome) and other high-performance polymers like those from Evonik (VESTAKEEP® PEEK). Its competitive edge is built on a first-mover advantage, a proven 20+ year clinical safety record with zero material-related recalls, and a comprehensive partnership model that includes regulatory and design support.